Liga Panamericana de Asociaciones de Reumatologia (PANLAR)
With
Janssen Research & Development, LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Consecutive patients with a diagnosis of SLE will be included. Patients should meet at least one ofthe classification criteria: ACR 1982/1997 (1) and/or SLICC 2012 (2) to determine the efficacy of calcineurin inhibitor-containing treatment regimens in LN cohorts by ethnic groups.
Age ≥18 years old.
Patients and controls that volunteer toparticipate and sign the informed consent
You may not be if
Patients with other systemic autoimmune diseases or overlap syndrome (rheumatoid arthritis, systemic sclerosis, dermatomyositis, systemic vasculitis and others).
Patients who have urinary infection, pregnancy or have a history of hepatitis B, C or HIV virus infection.
Those patients presenting with antiphospholipid syndrome (APS) associated with lupus will not be excluded from the study.
Clareo Health | Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
